A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
Clinical trial NCT03279146 · COMPLETED
Trial details
- NCT number
- NCT03279146
- Sponsor
- ContraVir Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-06
- Primary completion
- 2018-06-09
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.